๐Ÿ”Ž Trials Near Me

Home โ€บ Lymphoma

Lymphoma clinical trials recruiting in the U.S.

140 studies for Lymphoma are recruiting participants at sites across the United States.

Lymphoma is a cancer affecting the immune system. Hodgkins Lymphoma and Non Hodgkins Lymphoma are types of lymphoma. Learn about symptoms and treatments.

Cities with the most studies

By state

Recently updated studies

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Nov 13, 2026 ยท NCT02974647

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

RecruitingPhase 1/2
6 Months โ€“ 17 Years ยท All sexes ยท Updated Nov 13, 2026 ยท NCT02332668

Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

RecruitingPhase 1/2
Ages 18 to 120 ยท All sexes ยท Updated Nov 12, 2026 ยท NCT03223610

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT06218602

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

RecruitingPhase 2
Ages 12 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT03258567

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 120 ยท All sexes ยท Updated Nov 9, 2026 ยท NCT06856226

Living Well With Lymphoma

Recruiting
Ages 18 and older ยท All sexes ยท Updated Nov 9, 2026 ยท NCT06047626

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older ยท All sexes ยท Updated Nov 9, 2026 ยท NCT05237986

HPC Offered for PRESERVE Expansion

RecruitingObservational study
Ages 12 to 80 ยท All sexes ยท Updated Nov 6, 2026 ยท NCT07145411

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT06084936

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT05366881

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT07188558

Mosaic Trial for Stem Cell Transplant Recipients

Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 30, 2026 ยท NCT06960993

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Oct 30, 2026 ยท NCT05371132

Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Oct 29, 2026 ยท NCT07583810

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
Ages 0 to 38 ยท All sexes ยท Updated Oct 29, 2026 ยท NCT06131801

HEME Home Transfusion Program

Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 28, 2026 ยท NCT06487247

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.